Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To Come

The coronavirus pandemic will have a yearslong impact on biotech stocks, experts say, as investors cast aside common concerns about biotech companies and focus on the industry battle to develop winning Covid-19 treatments or vaccines.

Fervor over the race for the first coronavirus vaccine has led to skyrocketing valuations for previously unknown biotech stocks. Leaders so far in the process include Moderna (MRNA), BioNTech (BNTX) and Inovio Pharmaceuticals (INO).

Read more…